Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laura Sbarcea"'
Autor:
Ionut Ledeti, Renata Varut, Cristina Trandafirescu, Titus Vlase, Lenuta-Maria Suta, Cristina Dehelean, Adriana Ledeti, Gabriela Vlase, Laura Sbarcea, Denisa Circioban
Publikováno v:
Journal of Thermal Analysis and Calorimetry. 142:1951-1961
A series of five guest–host inclusion complexes containing the antimalarial and anticancer agent artesunate (ATS) were obtained and characterized in the present study. Different cyclodextrins (CDNs) were used as hosts [α-cyclodextrin (CDN1), β-cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fc3659b72402457d0e713da89a69065
https://doi.org/10.1007/s10973-020-09975-3
https://doi.org/10.1007/s10973-020-09975-3
Autor:
Minodora Andor, Claudia Temereancă, Laura Sbârcea, Adriana Ledeți, Dana Emilia Man, Cristian Mornoș, Amalia Ridichie, Denisa Cîrcioban, Gabriela Vlase, Paul Barvinschi, Angela Caunii, Renata-Maria Văruţ, Cristina Maria Trandafirescu, Valentina Buda, Ionuț Ledeți, Matilda Rădulescu
Publikováno v:
Molecules, Vol 29, Iss 10, p 2209 (2024)
Olmesartan medoxomil (OLM) is a selective angiotensin II receptor antagonist used in the treatment of hypertension. Its therapeutic potential is limited by its poor water solubility, leading to poor bioavailability. Encapsulation of the drug substanc
Externí odkaz:
https://doaj.org/article/b9ea04249fda4e5fbfd0bbaba9fc5d97
Publikováno v:
Clinical Problems COPD.
Background: Cardiovascular disorders represent the most frequent comorbidities as well as an increased risk of mortality in chronic obstructive pulmonary disease (COPD). Objective. The main goal is to analyze the cardiovascular profile of COPD patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2bdcfac5fd26e8b70cfc1744b2af5ec
https://doi.org/10.1183/1393003.congress-2017.pa3607
https://doi.org/10.1183/1393003.congress-2017.pa3607
Autor:
Laura Sbârcea, Ionuț-Mihai Tănase, Adriana Ledeți, Denisa Cîrcioban, Gabriela Vlase, Paul Barvinschi, Marinela Miclău, Renata-Maria Văruţ, Oana Suciu, Ionuț Ledeți
Publikováno v:
Molecules, Vol 26, Iss 6, p 1690 (2021)
Risperidone (RSP) is an atypical antipsychotic drug used in treating schizophrenia, behavioral, and psychological symptoms of dementia and irritability associated with autism. The drug substance is practically insoluble in water and exhibits high lip
Externí odkaz:
https://doaj.org/article/6a7f01e9cb7248f5a3622f2611e32ace
Autor:
Laura Sbârcea, Ionuț-Mihai Tănase, Adriana Ledeți, Denisa Cîrcioban, Gabriela Vlase, Paul Barvinschi, Marinela Miclău, Renata-Maria Văruţ, Cristina Trandafirescu, Ionuț Ledeți
Publikováno v:
Molecules, Vol 25, Iss 23, p 5694 (2020)
Risperidone (RSP) is an atypical antipsychotic drug which acts as a potent antagonist of serotonin-2 (5TH2) and dopamine-2 (D2) receptors in the brain; it is used to treat schizophrenia, behavioral and psychological symptoms of dementia and irritabil
Externí odkaz:
https://doaj.org/article/778f75f559ac4409ae2a45f968265497
Autor:
Lucreția Udrescu, Laura Sbârcea, Adriana Fuliaș, Ionuț Ledeți, Gabriela Vlase, Paul Barvinschi, Ludovic Kurunczi
Publikováno v:
Journal of Spectroscopy, Vol 2014 (2014)
Externí odkaz:
https://doaj.org/article/b3e65f8c5f4840cfba460ffdf0d946c7